Will There Ever Be Enough Straws to Break Corporate Health Care Managers' Impunity's Back? - Novartis Settles Yet Again, This Time for Bribing Doctors

boards of directors bribery conflicts of interest deception executive compensation health care corruption impunity marketing Novartis

Will There Ever Be Enough Straws to Break Corporate Health Care Managers' Impunity's Back? - Novartis Settles Yet Again, This Time for Bribing Doctors

Unknown 3/25/2016 Komentar

Umpteenth verse, same as the first...As just reported by Bloomberg,Novartis AG said it agreed to pay $25 million to settle a U.S. Securities and Exchange Commission case that claimed the Swiss drugmaker paid bribes to health...

Baca selengkapnya

Phooled Again - More Settlements Suggesting Bad Behavior by Big Pharma/ Biotech

adulterated devices bribery Bristol-Myers-Squibb crime deception deferred prosecution agreement Genzyme intimidation legal settlements Pfizer Sanofi-Aventis

Phooled Again - More Settlements Suggesting Bad Behavior by Big Pharma/ Biotech

Unknown 10/16/2015 Komentar

Once again, here is a roundup of cases showing big multi-national pharmaceutical and biotechnology companies are up to their usual tricks.Presented in alphabetical order...Bristol-Myers Squibb Settles Charges of Bribery...

Baca selengkapnya

Once More with Feeling - Amgen Again Settles Allegations of Misbranding, But Why Bother?

Amgen bribery deception kickbacks legal settlements marketing

Once More with Feeling - Amgen Again Settles Allegations of Misbranding, But Why Bother?

Unknown 8/21/2015 Komentar

The Latest Settlement Biotechnology giant Amgen has just reached another settlement of allegations that it unfairly, deceptively or misleadingly marketed its drug. Per the Los Angeles Times,Amgen Inc. has agreed to pay $71...

Baca selengkapnya

None Dare Call It Health Care Corruption

anechoic effect bribery cancer Columbia University crime fraud health care corruption

None Dare Call It Health Care Corruption

Unknown 1/29/2015 Komentar

... even when allegedly a prominent academic physician's traded referrals of cancer patients to a law firm, resulting in referral fees to a prominent politician who worked for the firm, for government research grants to...

Baca selengkapnya